The results indicated that among the included variables, qHBsAg (p = 0.031) and ΔTBiL (p = 0.002) were independent factors influencing the clinical cure rate in patients with CHB or compensated cirrhosis treated with sequential or combined Peg-IFN-α-2b. This evidence concerns the gene IFNA2 and Cirrhosis.